Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Limelight Networks (LLNW)

Limelight Networks (LLNW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Edgio, Inc. f/k/a Limelight Networks, Inc. Investors to Secure Counsel Before Important June 26 Deadline in Securities Class Action - EGIO, LLNW

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edgio, Inc. f/k/a Limelight Networks, Inc. (NASDAQ:...

EGIO : 1.1100 (-19.57%)
LLNW : 2.46 (+1.65%)
EQUITY ALERT: TOP RANKED ROSEN LAW FIRM Encourages Edgio, Inc. f/k/a Limelight Networks, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EGIO, LLNW

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edgio, Inc. f/k/a Limelight Networks, Inc. (NASDAQ: EGIO,...

EGIO : 1.1100 (-19.57%)
LLNW : 2.46 (+1.65%)
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Edgio, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Edgio, Inc. (“Edgio” or “the Company”) (NASDAQ: EGIO )...

LLNW : 2.46 (+1.65%)
EGIO : 1.1100 (-19.57%)
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Edgio, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Edgio, Inc. (“Edgio” or “the Company”) (NASDAQ: EGIO )...

LLNW : 2.46 (+1.65%)
EGIO : 1.1100 (-19.57%)
Why Limelight Networks Sank 13% on Thursday

The edge services platform is getting sued by a shareholder over its proxy statement.

LLNW : 2.46 (+1.65%)
Limelight Networks to Present at Upcoming Investor Conferences

Limelight Networks, Inc. (Nasdaq: LLNW), a leading provider of content delivery services and AppOps at the edge, today announced participation at the following investor conferences in June 2022:

LLNW : 2.46 (+1.65%)
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Limelight Networks, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Limelight Networks, Inc. (“Limelight” or “the Company”)...

LLNW : 2.46 (+1.65%)
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Limelight Networks, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Limelight Networks, Inc. (“Limelight” or “the Company”)...

LLNW : 2.46 (+1.65%)
Limelight Networks Stock is a Speculative Turnaround Opportunity

Internet content delivery network (CDN) provider Limelight Networks (NASDAQ: LLNW) shares plunged on its fiscal Q1 2022 earnings results.

LLNW : 2.46 (+1.65%)
Teladoc, Limelight, and NCR Are Bouncing Back Today (but They Still Look Cheap)

Smart investors buy great companies when their stocks are cheap. This looks like three of those opportunities.

COMP : 6.41 (+0.94%)
TDOC : 9.21 (+2.33%)
LLNW : 2.46 (+1.65%)
NCR : 27.08 (+3.24%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar